Pinachyan K - Search Results

1

A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient.

Miesbach W, Mulders G, Breederveld D, Pinachyan K, Le Quellec S, Pabinger I. Miesbach W, et al. Among authors: pinachyan k. Orphanet J Rare Dis. 2024 May 13;19(1):193. doi: 10.1186/s13023-024-03181-2. Orphanet J Rare Dis. 2024. PMID: 38741157 Free PMC article. Review.

2

Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review.

Ay C, Napolitano M, Hassoun A, Tomic R, Martin C, Seifert W, Pinachyan K, Oldenburg J. Ay C, et al. Among authors: pinachyan k. Haemophilia. 2024 May;30(3):577-588. doi: 10.1111/hae.15001. Epub 2024 Mar 29. Haemophilia. 2024. PMID: 38549463 Review.

3

Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.

Coppens M, Pipe SW, Miesbach W, Astermark J, Recht M, van der Valk P, Ewenstein B, Pinachyan K, Galante N, Le Quellec S, Monahan PE, Leebeek FWG; HOPE-B Investigators. Coppens M, et al. Among authors: pinachyan k. Lancet Haematol. 2024 Apr;11(4):e265-e275. doi: 10.1016/S2352-3026(24)00006-1. Epub 2024 Mar 1. Lancet Haematol. 2024. PMID: 38437857 Clinical Trial.

4

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review.

Ay C, Frenzel L, Pinachyan K, Le Quellec S. Ay C, et al. Among authors: pinachyan k. Haemophilia. 2024 Jan;30(1):5-15. doi: 10.1111/hae.14907. Epub 2023 Dec 18. Haemophilia. 2024. PMID: 38111029 Review.

5

The current challenges faced by people with hemophilia B.

Miesbach W, von Drygalski A, Smith C, Sivamurthy K, Pinachyan K, Bensen-Kennedy D, Drelich D, Kulkarni R. Miesbach W, et al. Among authors: pinachyan k. Eur J Haematol. 2024 Mar;112(3):339-349. doi: 10.1111/ejh.14135. Epub 2023 Dec 11. Eur J Haematol. 2024. PMID: 38082533 Review.

6

Analysis of pooled real-world data from Germany, Italy, and the United States of rVIII-SingleChain compared with standard- and long-acting FVIII products for prophylaxis of hemophilia A.

Olivieri M, Simpson M, Yan S, Fedorovsky J, Zhang X, Tomic R, Pinachyan K, Mancuso ME. Olivieri M, et al. Among authors: pinachyan k. Curr Med Res Opin. 2022 Jul;38(7):1133-1139. doi: 10.1080/03007995.2022.2062180. Epub 2022 May 2. Curr Med Res Opin. 2022. PMID: 35387548

7

Assessing cancer drugs for reimbursement: methodology, relationship between effect size and medical need.

de Sahb-Berkovitch R, Woronoff-Lemsi MC, Molimard M; participates of Round Table n° 7 Giens 2009. de Sahb-Berkovitch R, et al. Therapie. 2010 Jul-Aug;65(4):373-7, 367-72. doi: 10.2515/therapie/2010042. Epub 2010 Sep 21. Therapie. 2010. PMID: 20854761 English, French.

8

Critères et méthodologie d'évaluation au remboursement des anticancéreux.

Sahb-Berkovitch Rd, Woronoff-Lemsi MC, Molimard M; les participants de la Table Ronde n°7 de Giens 2009. Sahb-Berkovitch Rd, et al. Therapie. 2010 Jul-Aug;65(4):367-72. doi: 10.2515/therapie/20010041. Therapie. 2010. PMID: 27393114 French. No abstract available.

9

Collections of human biological samples for scientific purposes. Why do current regulation need to be clarified and how?

Deplanque D, Birraux G, Bertoye PH, Postaire E; Round Table N degrees 7, Giens XXIV. Deplanque D, et al. Therapie. 2009 Jul-Aug;64(4):259-67. doi: 10.2515/therapie/2009046. Epub 2009 Oct 7. Therapie. 2009. PMID: 19804706 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page